A Splenic Infarction Related to Parainfluenza Infection in a Patient with AML: Lessons for COVID-19
| dc.contributor.author | Sahu, Kamal Kant | |
| dc.contributor.author | Vogt, Bennett E. | |
| dc.contributor.author | Shanahan, Lindsey | |
| dc.contributor.author | Cerny, Jan | |
| dc.date | 2022-08-11T08:08:11.000 | |
| dc.date.accessioned | 2022-08-23T15:45:19Z | |
| dc.date.available | 2022-08-23T15:45:19Z | |
| dc.date.issued | 2021-09-02 | |
| dc.date.submitted | 2021-09-30 | |
| dc.identifier.citation | <p>Sahu KK, E Vogt B, Shanahan L, Cerny J. A Splenic Infarction Related to Parainfluenza Infection in a Patient with AML: Lessons for COVID-19. Acta Biomed. 2021 Sep 2;92(4):e2021256. doi: 10.23750/abm.v92i4.11095. PMID: 34487090. <a href="https://doi.org/10.23750/abm.v92i4.11095">Link to article on publisher's site</a></p> | |
| dc.identifier.issn | 0392-4203 (Linking) | |
| dc.identifier.doi | 10.23750/abm.v92i4.11095 | |
| dc.identifier.pmid | 34487090 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14038/27501 | |
| dc.description.abstract | Infection related thrombosis is a well-known entity. Antigen burden, immune response, complement activation, pro-coagulant condition, and smoking are only a few amongst the multiple risk factors which interplay in the development of thrombosis in any given case. Viral infections are amongst the many inciting factors known to predispose a prothrombotic state. We hereby report a known case of acute myelogenous leukemia, status post allogeneic stem cell trans-plantation who presented with two discrete episodes of sore throat and left upper quadrant pain. Infectious workup confirmed parainfluenza virus 3 on the first occasion, and rhinovirus infection on the second occasion. Computed tomography of the abdomen during both times suggested a splenic infarction. A comprehensive thrombotic workup was negative which suggested the diagnosis of viral infection-related splenic infarction. This case highlights the importance of caring for the potential eventualities of coagulopathy in cancer and other immunocompromised patients infected during the COVID-19 pandemic. | |
| dc.language.iso | en_US | |
| dc.relation | <p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=34487090&dopt=Abstract">Link to Article in PubMed</a></p> | |
| dc.relation.url | https://doi.org/10.23750/abm.v92i4.11095 | |
| dc.subject | Cardiovascular Diseases | |
| dc.subject | Hemic and Lymphatic Diseases | |
| dc.subject | Infectious Disease | |
| dc.subject | Pathological Conditions, Signs and Symptoms | |
| dc.subject | Virus Diseases | |
| dc.title | A Splenic Infarction Related to Parainfluenza Infection in a Patient with AML: Lessons for COVID-19 | |
| dc.type | Journal Article | |
| dc.source.journaltitle | Acta bio-medica : Atenei Parmensis | |
| dc.source.volume | 92 | |
| dc.source.issue | 4 | |
| dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/covid19/301 | |
| dc.identifier.contextkey | 25210838 | |
| html.description.abstract | <p>Infection related thrombosis is a well-known entity. Antigen burden, immune response, complement activation, pro-coagulant condition, and smoking are only a few amongst the multiple risk factors which interplay in the development of thrombosis in any given case. Viral infections are amongst the many inciting factors known to predispose a prothrombotic state. We hereby report a known case of acute myelogenous leukemia, status post allogeneic stem cell trans-plantation who presented with two discrete episodes of sore throat and left upper quadrant pain. Infectious workup confirmed parainfluenza virus 3 on the first occasion, and rhinovirus infection on the second occasion. Computed tomography of the abdomen during both times suggested a splenic infarction. A comprehensive thrombotic workup was negative which suggested the diagnosis of viral infection-related splenic infarction. This case highlights the importance of caring for the potential eventualities of coagulopathy in cancer and other immunocompromised patients infected during the COVID-19 pandemic.</p> | |
| dc.identifier.submissionpath | covid19/301 | |
| dc.contributor.department | School of Medicine | |
| dc.contributor.department | Department of Medicine, Division of Hematology Oncology | |
| dc.source.pages | e2021256 |